New drug ZT-01 aims to stop dangerous nighttime hypos in type 1 diabetes
Disease control
Recruiting now
This study tests whether ZT-01, a nightly self-injected drug, can reduce dangerous low blood sugar episodes during sleep in adults with type 1 diabetes. About 186 participants will receive either ZT-01 or a placebo for 4 weeks each, while wearing a continuous glucose monitor. The…
Phase: PHASE2 • Sponsor: Zucara Therapeutics Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC